RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 

Regulatory Focus™ > News Articles > EMA-FDA Joint GMP and GCP Inspection Pilot Programs

EMA-FDA Joint GMP and GCP Inspection Pilot Programs

Posted 01 October 2011 | By Michelle Conan-Cibotti, PhD, RAC

The global harmonization of regulatory requirements for the registration of pharmaceutical products started in the 1990s with the International Conference on Harmonisation (ICH). Ensuring consistent interpretation and implementation of ICH guidelines and continuous delivery of safe and effective products to consumers remains a challenge for regulators and industries.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.